BIOGEN INC. Cash And Cash Equivalents At Carrying Value

Quick Answer

BIOGEN INC. reported Cash And Cash Equivalents At Carrying Value of $2.91 billion for the year ending 2019.

  • BIOGEN INC. showed an increase of +137.9% in Cash And Cash Equivalents At Carrying Value from 2018 to 2019.
  • This data is from BIOGEN INC.'s annual report (Form 10-K), filed with the SEC on February 6, 2020.
  • XBRL data for this metric is available from 2006 to 2019 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 14 years of available data (2006 to 2019), BIOGEN INC.'s Cash And Cash Equivalents At Carrying Value has grown by 340.6%.
  • Historical annual values: Fiscal year 2019: $2.91 billion | Fiscal year 2018: $1.22 billion | Fiscal year 2017: $1.57 billion | Fiscal year 2016: $2.33 billion | Fiscal year 2015: $1.31 billion | Fiscal year 2014: $1.20 billion | Fiscal year 2013: $602.60 million | Fiscal year 2012: $570.70 million | Fiscal year 2011: $514.54 million | Fiscal year 2010: $759.60 million | Fiscal year 2009: $581.89 million | Fiscal year 2008: $622.39 million | Fiscal year 2007: $659.66 million | Fiscal year 2006: $661.38 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: